Observational studyClinical and experimental nephrology2019

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Shuichi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.